Molecular mechanisms associated with the metastatic nature of SCLC include the overexpression of nuclear factor I B (NFIB) and MYC proto-oncogene, as well as neuroendocrine differentiation markers such as neural cell adhesion molecule (NCAM), which collectively enhance metastatic capacity [13,15]. Here, NFIB is linked to small cell lung carcinoma.